Literature DB >> 32459932

Lung-Cancer Screening and the NELSON Trial. Reply.

Harry J de Koning1, Carlijn M van der Aalst1, Matthijs Oudkerk2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32459932     DOI： 10.1056/NEJMc2004224

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.

Authors:  Matthijs Oudkerk; ShiYuan Liu; Marjolein A Heuvelmans; Joan E Walter; John K Field
Journal:  Nat Rev Clin Oncol       Date:  2020-10-12       Impact factor: 66.675

2.  Seasonal prevalence and characteristics of low-dose CT detected lung nodules in a general Dutch population.

Authors:  Harriet L Lancaster; Marjolein A Heuvelmans; Gert Jan Pelgrim; Mieneke Rook; Marius G J Kok; Ahmed Aown; Geertruida H de Bock; Maarten van den Berge; Harry J M Groen; Rozemarijn Vliegenthart
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

3.  Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.

Authors:  Rudolf Kaaks; Evangelia Christodoulou; Erna Motsch; Verena Katzke; Mark O Wielpütz; Hans-Ulrich Kauczor; Claus Peter Heussel; Monika Eichinger; Stefan Delorme
Journal:  Transl Lung Cancer Res       Date:  2022-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.